André Sousa is pursuing a PhD in Metabolism – Clinical and Experimental at the Faculty of Medicine, University of Porto. His research focuses on the metabolic paradox between prostate cancer and type 2 diabetes, exploring innovative biotechnological therapies based on aptamers. During his stay at the University of Pittsburgh, Pennsylvania, André will be engaged in the Molecular Biology and Cell Signaling field, aiming to deepen the understanding of how the type 2 diabetes environment influences prostate cancer at the cellular signaling, particularly through the modulation of membrane receptors and their ubiquitylation-driven recycling. This work is expected to yield significant insights and potentially lead to breakthrough treatments for prostate cancer.

University of Pittsburgh

Grant duration: 6 months